NCT07467720

Brief Summary

Study to Evaluate the Clinical Utility of Radiation Exposure Reduction (SECURE): Multi-site Rampart Guardian Peripheral Trial

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
7mo left

Started Aug 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress17%
Aug 2026May 2027

First Submitted

Initial submission to the registry

March 9, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 12, 2026

Completed
5 months until next milestone

Study Start

First participant enrolled

August 20, 2026

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2027

Last Updated

August 21, 2026

Status Verified

August 1, 2026

Enrollment Period

9 months

First QC Date

March 9, 2026

Last Update Submit

August 19, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • The difference in radiation exposure to the care team using a Raysafe i3 dosimeter badge.

    The difference in radiation exposure to the care team using a Raysafe i3 dosimeter badge. The two methods being compared are traditional lead aprons and shields and the RAMPART IC System (Guardian, Bunker, Shadow, and Sentry) with optional lead aprons in peripheral cases.

    Intraprocedural

Secondary Outcomes (1)

  • The difference in radiation exposure to the care team on a per body segment analysis using a Raysafe i3 dosimeter badge.

    Intraprocedural

Study Arms (2)

Traditional Lead Apron and Shields

NO INTERVENTION

These procedures will be have no intervention. The study team will use the traditional lead apron and shields in peripheral cases.

Rampart IC System

ACTIVE COMPARATOR

The study team will use the Rampart IC System (Guardian, Bunker, Shadow, and Sentry) with optional lead aprons in peripheral cases.

Device: Rampart IC System

Interventions

RAMPART IC System (Guardian, Bunker, Shadow, and Sentry) is a radiation protection system that the study team will use during peripheral cases.

Rampart IC System

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Member of the interventional care team
  • Elective peripheral procedure
  • The access site is the femoral artery
  • The treatment area is at or distal to the iliac artery

You may not qualify if:

  • Individuals who are not yet adults, pregnant women, or prisoners.
  • Urgent and emergent cases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Baylor Scott & White The Heart Hospital- Plano

Plano, Texas, 75093, United States

RECRUITING

Related Publications (3)

  • Klein LW, Miller DL, Balter S, Laskey W, Haines D, Norbash A, Mauro MA, Goldstein JA; Joint Inter-Society Task Force on Occupational Hazards in the Interventional Laboratory. Occupational health hazards in the interventional laboratory: time for a safer environment. Catheter Cardiovasc Interv. 2009 Feb 15;73(3):432-8. doi: 10.1002/ccd.21801.

    PMID: 19214981BACKGROUND
  • Occ Med. 2010;60(6):464-9

    BACKGROUND
  • Circulation: Cardiovascular Interventions. 2016,Volume: 9, Issue: 4, DOI: 10.1161/CIRCINTERVENTIONS.115.003273

    BACKGROUND

Central Study Contacts

Sarah Hale

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 9, 2026

First Posted

March 12, 2026

Study Start

August 20, 2026

Primary Completion (Estimated)

May 15, 2027

Study Completion (Estimated)

May 15, 2027

Last Updated

August 21, 2026

Record last verified: 2026-08

Locations